Vaccination against SARS-CoV-2: History, myths and facts
Keywords:
COVID-19, vaccination, adjuvants, SARS-CoV-2, immune responseAbstract
During this COVID-19 pandemic, we have been flooded with information about viruses and vaccines; however, we must be careful with what we listen to, because the information can be misinterpreted, we can doubt if it is reliable, or we can even transmit it in the wrong way. For this reason, in the following lines we will tell you a little about the history of vaccination, the process of developing vaccines, as well as some concepts of interest such as adjuvants and adverse reactions. Lastly, we will briefly review SARS-CoV-2 vaccines and their importance.
References
Conti, A. A. (2021). Vaccination through time: from the first smallpox vaccine to current vaccination campaigns against the covid-19 pandemic. Acta Biomed, 92(S6), e2021453. https://doi.org/10.23750/abm.v92iS6.12211.
Guimarães, L. E., Baker, B., Perricone, C., y Shoenfeld, Y. (2015). Vaccines, adjuvants and autoimmunity. Pharmacol Res, 100, 190-209. https://doi.org/10.1016/j.phrs.2015.08.003.
U.S. Department of Health and Human Services, Food and Drug Administration. Center for Biologics Evaluation and Research. (1999). Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a vaccine or related product. https://cutt.ly/gX5erxH.
World Health Organization. (2020, 22 de diciembre). mrna vaccines against covid-19: Pfizer-BioNTech covid-19 vaccine BNT162b2: prepared by the Strategic Advisory Group of Experts (sage) on immunization working group on covid-19 vaccines. https://apps.who.int/iris/handle/10665/338096.
Bennett, J. E., Dolin, R., y Blaser, M. J. (2015). Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Elsevier; Saunders.
Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., y Shoenfeld, Y. (2021). The sars-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev, 20(4),102792. https://doi.org/10.1016/j.autrev.2021.102792.
Organización Panamericana de la Salud. (2020, 7 de mayo). covid-19. Fases de desarrollo de una vacuna. https://cutt.ly/NCoLisL.
Ravichandran, S., Coyle, E., Klenow, L., Tang, J., Grubbs, G., Liu, S., Wang, T., Golding, H., y Khurana, S. (2020). Antibody signature induced by sars-CoV-2 spike protein immunogens in rabbits. Sci Transl Med, 12(550), eabc3539. https://doi.org/10.1126/scitranslmed.abc3539.
Marcellino, M. T., Di Timoteo, F., De Angelis, M., Oliva, A. (2021). Overview of the Main Anti- sars-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety. Infect Drug Resist, (14), 3459-3476. https://doi.org/10.2147/IDR.S315727.
Nutrimente. (2020, 8 de abril). Los componentes HUMORAL y CELULAR de la RESPUESTA INMUNE innata [Video]. YouTube. https://youtu.be/_G7lM3NXOSE.
Banerji, A., Wickner, P. G., Saff, R., Stone, C. A. Jr, Robinson, L. B., Long, A. A., Wolfson, A.R., Williams, P., Khan, D. A., Phillips, E., y Blumenthal, K. G. (2021). mrna Vaccines to Prevent covid-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. J Allergy Clin Immunol Pract, 9(4),1423-1437. https://doi.org/10.1016/j.jaip.2020.12.047.
Izda, V., Jeffries, M. A., y Sawalha, A. H. (2022, enero). covid-19: A review of therapeutic strategies and vaccine candidates. Clin Immunol, 222,108634. https://doi.org/10.1016/j.clim.2020.108634.
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Revista Digital Universitaria es editada por la Universidad Nacional Autónoma de México se distribuye bajo una Licencia Creative Commons Atribución-NoComercial 4.0 Internacional. Basada en una obra en http://revista.unam.mx/.
